Search results for "610"

showing 10 items of 1353 documents

Meta-analysis of Randomized Controlled Trials and Individual Patient Data Comparing Minimally Invasive With Open Oesophagectomy for Cancer

2021

Minimally invasive oesophagectomy (MIO) for oesophageal cancer may reduce surgical complications compared with open oesophagectomy. MIO is, however, technically challenging and may impair optimal oncological resection. The aim of the present study was to assess if MIO for cancer is beneficial.A systematic literature search in MEDLINE, Web of Science and CENTRAL was performed and randomized controlled trials (RCTs) comparing MIO with open oesophagectomy were included in a meta-analysis. Survival was analysed using individual patient data. Random-effects model was used for pooled estimates of perioperative effects.Among 3219 articles, six RCTs were identified including 822 patients. Three-yea…

medicine.medical_specialtyEsophageal Neoplasmsmedicine.medical_treatment610 Medicine & healthLower risklaw.inventionRandomized controlled triallawOpen ResectionMedicineHumansMinimally Invasive Surgical ProceduresRandomized Controlled Trials as Topic10217 Clinic for Visceral and Transplantation Surgerybusiness.industryCancerOdds ratioPerioperativeLength of Staymedicine.diseaseSurgery2746 SurgeryEsophagectomyTreatment OutcomeEsophagectomyMeta-analysisSurgerybusiness
researchProduct

Machine Perfusions in Liver Transplantation: The Evidence‐Based Position Paper of the Italian Society of Organ and Tissue Transplantation

2020

The use of machine perfusion (MP) in liver transplantation (LT) is spreading worldwide. However, its efficacy has not been demonstrated, and its proper clinical use has far to go to be widely implemented. The Società Italiana Trapianti d’Organo (SITO) promoted the development of an evidence-based position paper. A 3-step approach has been adopted to develop this position paper. First, SITO appointed a chair and a cochair who then assembled a working group with specific experience of MP in LT. The Guideline Development Group framed the clinical questions into a patient, intervention, control, and outcome (PICO) format, extracted and analyzed the available literature, ranked the quality of th…

medicine.medical_specialtyEvidence-based practice2747 TransplantationGRADE; donor after circulatory death; donor brain death; hypothermic machine; liver transplant; machine perfusion; normothermic machine; normothermic regional perfusion; position papermedicine.medical_treatmentDelphi methodMEDLINEhypothermic machine610 Medicine & healthdonor after circulatory deathliver perfusion machine030230 surgeryLiver transplantationnormothermic regional perfusionliver03 medical and health sciences0302 clinical medicinenormothermic machineHumansMedicineMedical physics10217 Clinic for Visceral and Transplantation SurgeryHumansItalyTransplantationMachine perfusionHepatologybusiness.industrymachine perfusionOrgan Preservationdonor brain deathperfusion machineInstitutional review boardLiver Transplantation2746 SurgeryPerfusionTransplantationliver transplantGRADEItalyPosition paper2721 Hepatology030211 gastroenterology & hepatologySurgerybusinessposition paperHumanLiver Transplantation
researchProduct

The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

2022

This update and revision of the international guideline for urticaria was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. It is a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the Global Allergy and Asthma European Network (GALEN) and its Urticaria and Angioedema Centers of Reference and Excellence (UCAREs and ACAREs), the European Dermatology Forum (EDF; EuroGuiDerm), and the Asia Pacific Association of Allergy, Asthma and Clinical Immunology with the participation of 64 delegates of 50 national and international soci…

medicine.medical_specialtyEvidence-based practicehivesmedia_common.quotation_subjectImmunologyeducation610DermatologyAngioedema/diagnosis030207 dermatology & venereal diseases03 medical and health sciencesurticaria0302 clinical medicineQuality of lifeExcellenceimmune system diseasesevidence-basedparasitic diseasesmedicinePrevalenceImmunology and Allergymedia_common.cataloged_instanceHumansitchEuropean unionskin and connective tissue diseaseswhealAsthmamedia_commonAngioedemabusiness.industryangioedemaConsensus conferenceGUIDELINES ; angioedema ; consensus ; evidence2̆010based ; hives ; itch ; mast cell ; urticaria ; whealGuidelinemedicine.diseaseAsthma3. Good healthddc:030228 respiratory systemconsensusFamily medicineChronic DiseaseQuality of LifeUrticaria/diagnosismedicine.symptombusinessmast cell600 Technik Medizin angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
researchProduct

Psoriasis: Embarking a dynamic shift in the skin microbiota

2021

Recent interest has arisen regarding the role of microbiome and its composition in the pathogenesis of psoriasis. Numerous studies have shown that there are alterations in skin flora arrangement between normal individuals and psoriatic patients. Psoriasis exacerbation could be interconnected with epidermal or mucosal colonization with streptococci, Malassezia, Staphylococcus aureus, or Candida albicans. The role of cutaneous and gut microbiome in psoriasis pathogenesis has recently been studied in both human and animal models. In this review, we try to evaluate various pathogenic mechanisms linking the microbiota and psoriasis. The literature research included peer-reviewed articles which i…

medicine.medical_specialtyExacerbation610 MedizinMEDLINESkin floraDermatology030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicine610 Medical sciencesPsoriasisCandida albicansmedicineAnimalsHumansPsoriasisMicrobiomeCandida albicansSkinMalasseziabiologybusiness.industryMicrobiotabiology.organism_classificationmedicine.diseaseDermatologyClinical trial030220 oncology & carcinogenesisMalasseziabusinessJournal of Cosmetic Dermatology
researchProduct

Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis

2021

Abstract The efficacy and safety of caplacizumab in individuals with acquired thrombotic thrombocytopenic purpura (aTTP) have been established in the phase 2 TITAN and phase 3 HERCULES trials. Integrated analysis of data from both trials was conducted to increase statistical power for assessing treatment differences in efficacy and safety outcomes. Caplacizumab was associated with a significant reduction in the number of deaths (0 vs 4; P < .05) and a significantly lower incidence of refractory TTP (0 vs 8; P < .05) vs placebo during the treatment period. Consistent with the individual trials, treatment with caplacizumab resulted in a faster time to platelet count response (ha…

medicine.medical_specialtyExacerbationThrombotic thrombocytopenic purpura030204 cardiovascular system & hematologyPlaceboGastroenterology03 medical and health sciences0302 clinical medicineFibrinolytic AgentsRefractoryInternal medicinemedicineHumans610 Medicine & healthAcquired Thrombotic Thrombocytopenic PurpuraPlasma ExchangePurpura Thrombotic Thrombocytopenicbusiness.industryHazard ratioHematologySingle-Domain Antibodiesmedicine.diseaseStimulus ReportTolerability030220 oncology & carcinogenesisCaplacizumabbusinessBlood Advances
researchProduct

Evaluation of efficacy and biocompatibility of a novel semisynthetic collagen matrix as a dural onlay graft in a large animal model

2011

Background Semisynthetic collagen matrices are promising duraplasty grafts with low risk of cerebrospinal fluid (CSF) fistulas, good tissue integration and minor foreign body reaction. The present study investigates the efficacy and biocompatibility of a novel semisynthetic bilayered collagen matrix (BCM, B. Braun Aesculap) as dural onlay graft for duraplasty. Methods Thirty-four pigs underwent osteoclastic trepanation, excision of the dura, and placement of a cortical defect, followed by duraplasty using BCM, Suturable DuraGen™ (Integra Neuroscience), or periosteum. CSF tightness and intraoperative handling of the grafts were evaluated. Pigs were sacrificed after 1 and 6 months for histolo…

medicine.medical_specialtyExperimental ResearchBiocompatibilityDura materSus scrofaClinical NeurologyTissue integration610Biocompatible MaterialsMatrix (biology)Medicine & Public Health; Neurology; Interventional Radiology; Neuroradiology; Neurosurgery; Minimally Invasive Surgery; Surgical OrthopedicsExtracellular matrix03 medical and health sciences0302 clinical medicineCollagen matricesDural substituteMaterials TestingmedicineAnimalsDuraplastyCerebrospinal fluid leakbusiness.industryBCMWatermedicine.diseaseDural defect repairCerebrospinal fluid leakExtracellular MatrixSurgerymedicine.anatomical_structureDuraGenCollagen matrix; Dural substitute; Dural defect repair; Duraplasty; Cerebrospinal fluid leak; BCM; DuraGen030220 oncology & carcinogenesisModels AnimalCollagen matrixFemaleTissue AdhesivesSurgeryCollagenDura MaterNeurology (clinical)businessCraniotomy030217 neurology & neurosurgeryLarge animalActa Neurochirurgica
researchProduct

Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review.

2019

Abstract The objective of this scoping review is to summarize the current use of pharmacokinetics for tailoring prophylaxis in hemophilia patients switching between clotting factor products. Patients with hemophilia may require switching of clotting factor concentrates due to a variety of factors, but there have been perceived risks associated with switching, such as inhibitor development or suboptimal protection due to inadequate dosing while titrating treatment. Studies that look at patients switching from one clotting factor concentrate to another are categorized in terms of their primary and/or secondary objectives, notably biosimilarity and comparative pharmacokinetic studies and inhib…

medicine.medical_specialtyFactor concentrate610 Medicine & healthReview Article030204 cardiovascular system & hematologyHemophilia ADrug SubstitutionHemophilia BFactor IX03 medical and health sciencesDrug substitution0302 clinical medicinePharmacokineticsmedicineDosingIntensive care medicineFactor IXClotting factorOriginal Articles: Haemostasisfactor IXFactor VIIIlcsh:RC633-647.5business.industryDosing regimenlcsh:Diseases of the blood and blood-forming organsHematology3. Good healthOnline‐only Articlesfactor VIII3121 General medicine internal medicine and other clinical medicinedrug substitution10032 Clinic for Oncology and Hematologydrug substitution; factor IX; factor VIII; hemophilia A; hemophilia Bhemophilia Bhemophilia Abusiness030215 immunologymedicine.drug
researchProduct

Individualized Monitoring of Muscle Recovery in Elite Badminton

2019

\(\bf Purpose:\) Individualized reference ranges for serum creatine kinase (CK) and urea are a promising tool for the assessment of recovery status in high-level endurance athletes. In this study, we investigated the application of this approach in racket sports, specifically for the monitoring of elite badminton players during the preparation for their world championships. \(\bf Methods:\) Seventeen elite badminton players were enrolled of which 15 could be included in the final analysis. Repeated measurements of CK and urea at recovered (R) and non-recovered (NR) time points were used for the stepwise individualization of group-based, prior reference ranges as well as for the evaluation o…

medicine.medical_specialtyGroup basedPhysiologyWord error rate610Reference rangeBayesianlcsh:Physiology03 medical and health sciencessymbols.namesakerecovery0302 clinical medicineStatistical significancePhysiology (medical)medicine030212 general & internal medicineddc:796reference rangeFisher's exact testMorningOriginal Researchlcsh:QP1-981business.industry030229 sport sciencesPhysical therapysymbolsSerum creatine kinasefatiguebusinesssportFrontiers in Physiology
researchProduct

Ambient carbon monoxide and daily mortality:a global time-series study in 337 cities

2021

Background Epidemiological evidence on short-term association between ambient carbon monoxide (CO) and mortality is inconclusive and limited to single cities, regions, or countries. Generalisation of results from previous studies is hindered by potential publication bias and different modelling approaches. We therefore assessed the association between short-term exposure to ambient CO and daily mortality in a multicity, multicountry setting. Methods We collected daily data on air pollution, meteorology, and total mortality from 337 cities in 18 countries or regions, covering various periods from 1979 to 2016. All included cities had at least 2 years of both CO and mortality data. We estimat…

medicine.medical_specialtyHealth (social science)OzoneAir pollutionMedicine (miscellaneous)Time Series610 Medicine & health010501 environmental sciencesmedicine.disease_cause01 natural sciencesDaily mortalityArbetsmedicin och miljömedicin03 medical and health scienceschemistry.chemical_compound0302 clinical medicine360 Social problems & social servicesAir PollutionEnvironmental healthEpidemiologyRisk of mortalitymedicineHumansNitrogen dioxide030212 general & internal medicineCities610 Medicine & healthAir quality indexlcsh:Environmental sciences0105 earth and related environmental sciencesMCClcsh:GE1-350PollutantAir PollutantsCarbon MonoxideHealth PolicyPublic Health Environmental and Occupational HealthPublic Health Global Health Social Medicine and EpidemiologyOccupational Health and Environmental HealthParticulatesAmbient carbon monoxideFolkhälsovetenskap global hälsa socialmedicin och epidemiologicarbon monoxide mortalitychemistryCardiovascular DiseasesEnvironmental scienceDeterminantes da Saúde e da DoençaGenotoxicidade Ambiental360 Social problems & social services
researchProduct

High prevalence and little awareness in patients with chronic inflammatory skin diseases and genital involvement.

2020

Background Genital involvement in patients with chronic inflammatory skin diseases is frequent, yet insufficiently acknowledged. Objective To evaluate the prevalence of genital symptoms in psoriasis and chronic urticaria patients, effects on quality of life, physician-patient relations and disease management. Patients and methods 100 patients with psoriasis and 100 with chronic urticaria from our outpatient clinic, as well as 50 healthy controls were included. Data was collected using questionnaires developed by dermatological experts. Results Out of 250 subjects, 74 % had already experienced genital symptoms - 70 % of psoriasis patients and 58 % of urticaria patients. Seven out of ten even…

medicine.medical_specialtyHigh prevalenceUrticariabusiness.industry610 MedizinDermatologymedicine.diseaseDermatologyQuality of lifePsoriasis610 Medical sciencesChronic DiseasemedicinePrevalenceQuality of LifeOutpatient clinicHumansPsoriasisSex organIn patientGenitaliaDisease management (health)skin and connective tissue diseasesbusinessChronic urticariaJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDGReferences
researchProduct